Thrombomodulin Facilitates Peripheral Nerve Regeneration Through Regulating M1/M2 Switching

Overview

Journal J Neuroinflammation

Publisher Biomed Central

Date 2020 Aug 18

PMID 32799887

Citations 26

Authors

Tzu-Chieh Huang

Hua-Lin Wu

Szu-Han Chen

Yun-Ting Wang

Chia-Ching Wu

Affiliations

Soon will be listed here.

Abstract

Background: Excessive inflammation within damaged tissue usually leads to delayed or insufficient regeneration, and nerves in the peripheral nervous system (PNS) generally do not recover fully following damage. Consequently, there is growing interest in whether modulation of the inflammatory response could help to promote nerve regeneration in the PNS. However, to date, there are no practical therapeutic strategies for manipulating inflammation after nerve injury. Thrombomodulin (TM) is a transmembrane glycoprotein containing five domains. The lectin-like domain of TM has the ability to suppress the inflammatory response. However, whether TM can modulate inflammation in the PNS during nerve regeneration has yet to be elucidated.

Methods: We investigated the role of TM in switching proinflammatory type 1 macrophages (M1) to anti-inflammatory type 2 macrophages (M2) in a human monocytic cell line (THP-1) and evaluated the therapeutic application of TM in transected sciatic nerve injury in rats.

Results: The administration of TM during M1 induction significantly reduced the expression levels of inflammatory cytokines, including TNF-a (p < 0.05), IL-6 (p < 0.05), and CD86 (p < 0.05), in THP-1 cells. Simultaneously, the expression levels of M2 markers, including IL-10 (p < 0.05) and CD206 (p < 0.05), were significantly increased in TM-treated THP-1 cells. Inhibition of IL-4R-c-Myc-pSTAT6-PPARγ signaling abolished the expression levels of IL-10 (p < 0.05) and CD206 (p < 0.05). The conditioned medium (CM) collected from M1 cells triggered an inflammatory response in primary Schwann cells, while CM collected from M1 cells treated with TM resulted in a dose-dependent reduction in inflammation. TM treatment led to better nerve regeneration when tested 6 weeks after injury and preserved effector muscle function. In addition, TM treatment reduced macrophage infiltration at the site of injury and led to potent M1 to M2 transition, thus indicating the anti-inflammatory capacity of TM.

Conclusions: Collectively, our findings demonstrate the anti-inflammatory role of TM during nerve regeneration. Therefore, TM represents a potential drug for the promotion and modulation of functional recovery in peripheral nerves that acts by regulating the M1/M2 ratio.

Citing Articles

Enhanced mitochondrial function and delivery from adipose-derived stem cell spheres via the EZH2-H3K27me3-PPARγ pathway for advanced therapy.

Chang M, Chu D, Lin S, Lee J, Vu T, Vu H Stem Cell Res Ther. 2025; 16(1):129.

PMID: 40069892 PMC: 11899936. DOI: 10.1186/s13287-025-04164-1.

Molecular and cellular mechanisms underlying peripheral nerve injury-induced cellular ecological shifts: Implications for neuroregeneration.

Wu L, He J, Shen N, Chen S IBRO Neurosci Rep. 2025; 18:120-129.

PMID: 39877591 PMC: 11773043. DOI: 10.1016/j.ibneur.2024.12.013.

Recombinant Thrombomodulin Domain 1 Modulates Macrophage Polarization and Enhances Healing in Corneal Alkali Burns.

Chang C, Peng I, Huang Y Invest Ophthalmol Vis Sci. 2025; 66(1):21.

PMID: 39786758 PMC: 11725990. DOI: 10.1167/iovs.66.1.21.

Static Magnetic Stimulation and Magnetic Microwires Synergistically Enhance and Guide Neurite Outgrowth.

Neuman K, Zhang X, Lejeune B, Pizzarella D, Vazquez M, Lewis L Adv Healthc Mater. 2024; 14(3):e2403956.

PMID: 39568232 PMC: 11773108. DOI: 10.1002/adhm.202403956.

Multilevel analysis of the central-peripheral-target organ pathway: contributing to recovery after peripheral nerve injury.

Song X, Li R, Chu X, Li Q, Li R, Li Q Neural Regen Res. 2024; 20(10):2807-2822.

PMID: 39435615 PMC: 11826472. DOI: 10.4103/NRR.NRR-D-24-00641.

References

Ma C, Chang W, Shi G, Chang B, Cheng S, Shih Y . Recombinant thrombomodulin inhibits lipopolysaccharide-induced inflammatory response by blocking the functions of CD14. J Immunol. 2015; 194(4):1905-15. DOI: 10.4049/jimmunol.1400923. View

Rijneveld A, Weijer S, Florquin S, Esmon C, Meijers J, Speelman P . Thrombomodulin mutant mice with a strongly reduced capacity to generate activated protein C have an unaltered pulmonary immune response to respiratory pathogens and lipopolysaccharide. Blood. 2003; 103(5):1702-9. DOI: 10.1182/blood-2002-05-1380. View

Maruyama I, MAJERUS P . The turnover of thrombin-thrombomodulin complex in cultured human umbilical vein endothelial cells and A549 lung cancer cells. Endocytosis and degradation of thrombin. J Biol Chem. 1985; 260(29):15432-8. View

Liou J, Wu C, Chen B, Yen L, Wu K . Nonsteroidal anti-inflammatory drugs induced endothelial apoptosis by perturbing peroxisome proliferator-activated receptor-delta transcriptional pathway. Mol Pharmacol. 2008; 74(5):1399-406. DOI: 10.1124/mol.108.049569. View

Phillip West A, Brodsky I, Rahner C, Woo D, Erdjument-Bromage H, Tempst P . TLR signalling augments macrophage bactericidal activity through mitochondrial ROS. Nature. 2011; 472(7344):476-80. PMC: 3460538. DOI: 10.1038/nature09973. View

Sarker K, Abeyama K, Nishi J, Nakata M, Tokioka T, Nakajima T . Inhibition of thrombin-induced neuronal cell death by recombinant thrombomodulin and E5510, a synthetic thrombin receptor signaling inhibitor. Thromb Haemost. 1999; 82(3):1071-7. View

Gaudet A, Popovich P, Ramer M . Wallerian degeneration: gaining perspective on inflammatory events after peripheral nerve injury. J Neuroinflammation. 2011; 8:110. PMC: 3180276. DOI: 10.1186/1742-2094-8-110. View

Dun X, Carr L, Woodley P, Barry R, Drake L, Mindos T . Retracted: Macrophage-Derived Slit3 Controls Cell Migration and Axon Pathfinding in the Peripheral Nerve Bridge. Cell Rep. 2019; 26(6):1458-1472.e4. PMC: 6367597. DOI: 10.1016/j.celrep.2018.12.081. View

Odegaard J, Ricardo-Gonzalez R, Goforth M, Morel C, Subramanian V, Mukundan L . Macrophage-specific PPARgamma controls alternative activation and improves insulin resistance. Nature. 2007; 447(7148):1116-20. PMC: 2587297. DOI: 10.1038/nature05894. View

10.

Ren P, Zhang Y, Zhang X, An L, Lv H, He J . High-mobility group box 1 contributes to mechanical allodynia and spinal astrocytic activation in a mouse model of type 2 diabetes. Brain Res Bull. 2012; 88(4):332-7. DOI: 10.1016/j.brainresbull.2012.03.002. View

11.

Mohri M, Gonda Y, Oka M, Aoki Y, Gomi K, Kiyota T . The antithrombotic effects of recombinant human soluble thrombomodulin (rhsTM) on tissue factor-induced disseminated intravascular coagulation in crab-eating monkeys (Macaca fascicularis). Blood Coagul Fibrinolysis. 1997; 8(5):274-83. DOI: 10.1097/00001721-199707000-00003. View

12.

Peluffo H, Solari-Saquieres P, Negro-Demontel M, Francos-Quijorna I, Navarro X, Lopez-Vales R . CD300f immunoreceptor contributes to peripheral nerve regeneration by the modulation of macrophage inflammatory phenotype. J Neuroinflammation. 2015; 12:145. PMC: 4531482. DOI: 10.1186/s12974-015-0364-y. View

13.

Tugal D, Liao X, Jain M . Transcriptional control of macrophage polarization. Arterioscler Thromb Vasc Biol. 2013; 33(6):1135-44. DOI: 10.1161/ATVBAHA.113.301453. View

14.

Cattin A, Burden J, Van Emmenis L, Mackenzie F, Hoving J, Garcia Calavia N . Macrophage-Induced Blood Vessels Guide Schwann Cell-Mediated Regeneration of Peripheral Nerves. Cell. 2015; 162(5):1127-39. PMC: 4553238. DOI: 10.1016/j.cell.2015.07.021. View

15.

Tanaka J, Seki Y, Ishikura H, Tsubota M, Sekiguchi F, Yamaguchi K . Recombinant human soluble thrombomodulin prevents peripheral HMGB1-dependent hyperalgesia in rats. Br J Pharmacol. 2013; 170(6):1233-41. PMC: 3838698. DOI: 10.1111/bph.12396. View

16.

Wolter J, Schild L, Bock F, Hellwig A, Gadi I, Al-Dabet M . Thrombomodulin-dependent protein C activation is required for mitochondrial function and myelination in the central nervous system. J Thromb Haemost. 2016; 14(11):2212-2226. DOI: 10.1111/jth.13494. View

17.

Kobayashi M, Tamari K, Al Salihi M, Nishida K, Takeuchi K . Anti-high mobility group box 1 antibody suppresses local inflammatory reaction and facilitates olfactory nerve recovery following injury. J Neuroinflammation. 2018; 15(1):124. PMC: 5921993. DOI: 10.1186/s12974-018-1168-7. View

18.

Genin M, Clement F, Fattaccioli A, Raes M, Michiels C . M1 and M2 macrophages derived from THP-1 cells differentially modulate the response of cancer cells to etoposide. BMC Cancer. 2015; 15:577. PMC: 4545815. DOI: 10.1186/s12885-015-1546-9. View

19.

Jia Y, Yang W, Zhang K, Qiu S, Xu J, Wang C . Nanofiber arrangement regulates peripheral nerve regeneration through differential modulation of macrophage phenotypes. Acta Biomater. 2018; 83:291-301. DOI: 10.1016/j.actbio.2018.10.040. View

20.

Su Z, Zhang P, Yu Y, Lu H, Liu Y, Ni P . HMGB1 Facilitated Macrophage Reprogramming towards a Proinflammatory M1-like Phenotype in Experimental Autoimmune Myocarditis Development. Sci Rep. 2016; 6:21884. PMC: 4761996. DOI: 10.1038/srep21884. View